Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
NCT02550756
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class
Conditions
Morton's Neuroma
Interventions
DRUG:
CTNX-4975
Sponsor
Centrexion Therapeutics